Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia (Q35217408)

7 August 2017

title

Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia (English)

1 reference

7 August 2017

1 reference

1 reference

lymphoblastic leukemia

1 reference

7

Tefferi A

1 reference

7 August 2017

8

Litzow MR

1 reference

7 August 2017

4

Gertz MA

1 reference

7 August 2017

6

Lacy MQ

1 reference

7 August 2017

Kumar S

1

1 reference

7 August 2017

Chen MG

series ordinal

2

1 reference

7 August 2017

Gastineau DA

series ordinal

3

1 reference

7 August 2017

Inwards DJ

series ordinal

5

1 reference

7 August 2017

publication date

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

volume

17

1 reference

7 August 2017

issue

9

1 reference

7 August 2017

page(s)

1865-1870

1 reference

Acute lymphoblastic leukemia. A comprehensive review with emphasis on biology and therapy

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Chemotherapy versus transplantation in acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Effect of slow lymphocyte recovery and type of graft-versus-host disease prophylaxis on relapse after allogeneic bone marrow transplantation for acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Graft-versus-leukemia effects in T lineage and B lineage acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Generation of leukemia-reactive cytotoxic T lymphocyte clones from the HLA-identical bone marrow donor of a patient with leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Phenotype of recovering lymphoid cell populations after marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Mechanism of cytotoxicity by natural killer (NK) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

PERIPHERAL BLOOD T LYMPHOCYTES BEARING DR ANTIGEN AFTER BONE MARROW TRANSPLANTATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Successful reinduction of patients with acute lymphoblastic leukemia who relapse following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Donor leukocyte infusions in acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Successful prevention of hematological relapse for a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic bone marrow transplantation by donor leukocyte infusion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Lymphocyte reconstitution after allogeneic blood stem cell transplantation for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Rapid reappearance of large granular lymphocytes (LGL) with concomitant reconstitution of natural killer (NK) activity after human bone marrow transplantation (BMT)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Prophylactic use of human leukocyte interferon after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403055

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2403055

1 reference

7 August 2017

1 reference